Your browser doesn't support javascript.
loading
Nonpegylated liposomal doxorubicin combination regimen in patients with diffuse large B-cell lymphoma and cardiac comorbidity. Results of the HEART01 phase II trial conducted by the Fondazione Italiana Linfomi.
Luminari, Stefano; Viel, Elda; Ferreri, Andrés José Maria; Zaja, Francesco; Chimienti, Emanuela; Musuraca, Gerardo; Tucci, Alessandra; Balzarotti, Monica; Tani, Monica; Salvi, Francesca; Pesce, Emanuela A; Ferrari, Angela; Liberati, Anna M; Spadea, Antonio; Marino, Dario; Bruno-Ventre, Maria; Volpetti, Stefano; Bottelli, Chiara; Ravaioli, Elena; Merli, Francesco; Spina, Michele.
Afiliação
  • Luminari S; Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
  • Viel E; Department of Diagnostic, Clinic and Public Health Medicine, University of Modena and Reggio Emilia, Modena, Italy.
  • Ferreri AJM; Cardiology Unit, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy.
  • Zaja F; Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Chimienti E; Haematology Section, DISM, Azienda Sanitaria Universitaria Integrata S. M. Misericordia, Udine, Italy.
  • Musuraca G; Division of Medical Oncology A, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy.
  • Tucci A; Department of Hematology, Istituto Scientifico Romagnolo per Studio e Cura dei Tumori, Meldola, Forlì-Cesena, Italy.
  • Balzarotti M; Division of Hematology, Spedali Civili, Brescia, Italy.
  • Tani M; Hematology Unit, Humanitas Cancer Center, Rozzano, Milan, Italy.
  • Salvi F; Hematology Unit, Santa Maria delle Croci Hospital, Ravenna, Italy.
  • Pesce EA; Department of Hematology, SS Antonio E Biagio E Cesare Arrigo Hospital, Alessandria, Italy.
  • Ferrari A; Fondazione Italiana Linfomi Onlus, Italy.
  • Liberati AM; Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
  • Spadea A; Oncohematology, AO S. Maria di Terni, Terni, Italy.
  • Marino D; Hematology and Stem Cell Transplant Unit, Regina Elena National Cancer Institute, Rome, Italy.
  • Bruno-Ventre M; Division of Medical Oncology 1, Istituto Oncologico Veneto-IRCCS, Padova, Italy.
  • Volpetti S; Unit of Lymphoid Malignancies, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Bottelli C; Haematology Section, DISM, Azienda Sanitaria Universitaria Integrata S. M. Misericordia, Udine, Italy.
  • Ravaioli E; Division of Hematology, Spedali Civili, Brescia, Italy.
  • Merli F; Division of Medical Oncology A, National Cancer Center, Istituto di Ricovero e Cura a Carattere Scientifico, Aviano, Pordenone, Italy.
  • Spina M; Hematology, Arcispedale Santa Maria Nuova, Istituto di Ricovero e Cura a Carattere Scientifico, Reggio Emilia, Italy.
Hematol Oncol ; 36(1): 68-75, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28524259
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Cardiopatias Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doxorrubicina / Cardiopatias Tipo de estudo: Clinical_trials Limite: Aged / Female / Humans / Male País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article